OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 4.764 EUR 0.38%
Market Cap: 107m EUR

Wall Street
Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 15.606 EUR with a low forecast of 12.019 EUR and a high forecast of 22.05 EUR.

Lowest
Price Target
12.019 EUR
152% Upside
Average
Price Target
15.606 EUR
228% Upside
Highest
Price Target
22.05 EUR
363% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
ORKA
Oruka Therapeutics Inc
68% Upside
BAVA
Bavarian Nordic A/S
37% Upside
XNCR
Xencor Inc
81% Upside
RPTX
Repare Therapeutics Inc
40% Upside
RIGL
Rigel Pharmaceuticals Inc
10% Upside
MIRM
Mirum Pharmaceuticals Inc
30% Upside
301047
Sino Biological Inc
19% Upside
2157
Lepu Biopharma Co Ltd
99% Upside

Revenue
Forecast

Revenue Estimate
OSE Immunotherapeutics SA

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is 18%.

N/A
Past Growth
18%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

Net Income
Forecast

Net Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSE's stock price target?
Price Target
15.606 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 15.606 EUR with a low forecast of 12.019 EUR and a high forecast of 22.05 EUR.

What is OSE Immunotherapeutics SA's Revenue forecast?
Projected CAGR
18%

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is 18%.

Back to Top